Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.
Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs
Sala Uddin GM, Md. Rashed Nejum, Md. Rezuanul Islam and Md. Monirul Islam
Parasitic infections are the most prevalent in humans in developing countries and one third of the world population are infected by intestinal parasites. In addition, it affects millions of heads of livestock throughout the world. Global infections and widespread drug resistances exhibited by both protozoa and helminthes which have great challenge to present medicine. New medicine or bioactive may be talented solution of this problem. Combinatorial biosynthesis is one of the approaches for protecting parasitic infection but bioactive from natural origin provides diversity and structural complexity of the compounds with densely packed functional groups allowing maximum selectivity and interaction to the target. Currently the majority of antibiotics used in clinical practice are natural product origin. Living marine surfaces provide environment rich epibiotic microorganisms (e.g., bacteria) that produce bioactive compounds. By improving the culturability and using upgrade techniques it is possible to overcome the challenge of bioactive production. Microorganisms are currently accepted as the best renewable source of bioactive and marine living surface have great potential of producing novel bioactive compounds useful for further drug development. This review evaluate that marine surface associated bacteria are great source for production of novel antiprotozoal and anthelminthic compounds.